Trial intelligence / Profile preview

QLAIV in HIV-infected Children and Young Adults

NCT02474901Phase 2Completed

Sponsor
University of Colorado Denver
Start
Jul 2013
Primary completion
Mar 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of live attenuated influenza vaccine in influenza, sponsored by University of Colorado Denver. Started Jul 2013; status: completed.

02

Drugs

live attenuated influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT02474901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02474901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call